au.\*:("MCINTYRE, Roger S")
Results 1 to 25 of 87
Selection :
Aripiprazole for the Maintenance Treatment of Bipolar I Disorder: A ReviewMCINTYRE, Roger S.Clinical therapeutics. 2010, Vol 32, issn 0149-2918, S32-S38, SUPAArticle
Understanding Needs, Interactions, Treatment, and Expectations Among Individuals Affected by Bipolar Disorder or Schizophrenia: The UNITE Global SurveyMCINTYRE, Roger S.The Journal of clinical psychiatry. Supplement. 2009, Vol 70, Num 3, pp 5-11, 7 p.Article
The Role of Aripiprazole in Canada: A Review of Clinical and Drug Discontinuation DataMCINTYRE, Roger S.Clinical therapeutics. 2010, Vol 32, issn 0149-2918, 40 p., SUPASerial Issue
Using Measurement Strategies to Identify and Monitor Residual SymptomsMCINTYRE, Roger S.The Journal of clinical psychiatry. 2013, Vol 74, pp 14-18, issn 0160-6689, 5 p., SUP2Article
Balancing the Equation: Managing Comorbidities in Patients With Severe Mental IllnessMCINTYRE, Roger S.The Journal of clinical psychiatry. Supplement. 2009, Vol 70, Num 3, 40 p.Serial Issue
Asenapine: A Review of Acute and Extension Phase Data in Bipolar DisorderMCINTYRE, Roger S.CNS neuroscience & therapeutics (Print). 2011, Vol 17, Num 6, pp 645-648, issn 1755-5930, 4 p.Article
When Should You Move Beyond First-Line Therapy for Depression?MCINTYRE, Roger S.The Journal of clinical psychiatry. Supplement. 2010, Vol 71, Num 1, pp 16-20, 5 p.Article
Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and AdolescentsMCINTYRE, Roger S; JERRELL, Jeanette M.Archives of pediatrics & adolescent medicine. 2008, Vol 162, Num 10, pp 929-935, issn 1072-4710, 7 p.Article
Psychotropic drugs and adverse events in the treatment of bipolar disorders revisitedMCINTYRE, Roger S.The Journal of clinical psychiatry. Supplement. 2002, Vol 63, Num 3, pp 15-20Article
The Effects of Undertreated Chronic Medical Illnesses in Patients With Severe Mental DisordersFAGIOLINI, Andrea; GORACCI, Arianna.The Journal of clinical psychiatry. Supplement. 2009, Vol 70, Num 3, pp 22-29, 8 p.Article
Polypharmacy in Children and Adolescents Treated for Major Depressive Disorder : A Claims Database StudyMCINTYRE, Roger S; JERRELL, Jeanette M.The Journal of clinical psychiatry. 2009, Vol 70, Num 2, pp 240-246, issn 0160-6689, 7 p.Article
Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: A pooled, post hoc analysis from the asenapine development programSZEGEDI, Armin; JUN ZHAO; MCINTYRE, Roger S et al.Journal of affective disorders. 2013, Vol 150, Num 3, pp 745-752, issn 0165-0327, 8 p.Article
Aripiprazole in Schizophrenia and Schizoaffective Disorder: A ReviewSTIP, Emmanuel; TOURJMAN, Valérie.Clinical therapeutics. 2010, Vol 32, issn 0149-2918, S3-S20, SUPAArticle
Patterns of Discontinuation of Atypical Antipsychotics in the Province of Quebec: A Retrospective Prescription Claims Database AnalysisMOISAN, Jocelyne; GREGOIRE, Jean-Pierre.Clinical therapeutics. 2010, Vol 32, issn 0149-2918, S21-S31, SUPAArticle
A Cohort Study of the Prevalence and Impact of Comorbid Medical Conditions in Pediatric Bipolar Disorder : CHILDHOOD AND ADOLESCENT MENTAL HEALTHJERRELL, Jeanette M; MCINTYRE, Roger S; TRIPATHI, Avnish et al.The Journal of clinical psychiatry. 2010, Vol 71, Num 11, pp 1518-1525, issn 0160-6689, 8 p.Article
The human cost of not achieving full remission in depressionMCINTYRE, Roger S; O'DONOVAN, Claire.Canadian journal of psychiatry. 2004, Vol 49, Num 3, pp 10S-16S, issn 0706-7437, SUP1Article
Obesity in Patients With Severe Mental Illness: Overview and ManagementMCELROY, Susan L.The Journal of clinical psychiatry. Supplement. 2009, Vol 70, Num 3, pp 12-21, 10 p.Article
Comparing the Safety and Efficacy of Atypical Antipsychotics in Psychiatric Patients With Comorbid Medical IllnessesNEWCOMER, John W.The Journal of clinical psychiatry. Supplement. 2009, Vol 70, Num 3, pp 30-36, 7 p.Article
Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorderMCINTYRE, Roger S; KONARSKI, Jakub Z.The Journal of clinical psychiatry. Supplement. 2005, Vol 66, Num 3, pp 28-36, 9 p.Conference Paper
Creating a Health Care Team to Manage Chronic Medical Illnesses in Patients With Severe Mental Illness: The Public Policy PerspectiveKANE, John M.The Journal of clinical psychiatry. Supplement. 2009, Vol 70, Num 3, pp 37-42, 6 p.Article
Measurable outcomes in psychiatric disorders : Remission as a marker of wellnessMCINTYRE, Roger S; FALLU, Angelo; KONARSKI, Jakub Z et al.Clinical therapeutics. 2006, Vol 28, Num 11, pp 1882-1891, issn 0149-2918, 10 p.Conference Paper
Depression in the workforce: the intermediary effect of medical comorbidityMCINTYRE, Roger S; LIAUW, Samantha; TAYLOR, Valerie H et al.Journal of affective disorders. 2011, Vol 128, issn 0165-0327, S29-S36, SUP1Article
Economic Costs of Failure to Monitor Adverse Effects of Second-Generation Antipsychotics: An Underestimated FactorJERRELL, Jeanette M; MCINTYRE, Roger S; BLACK, George B et al.Psychiatric services (Washington, D.C.). 2012, Vol 63, Num 3, pp 202-204, issn 1075-2730, 3 p.Article
Mechanisms of antipsychotic-induced weight gainMCINTYRE, Roger S; MANCINI, Deborah A; BASILE, Vincenzo S et al.The Journal of clinical psychiatry. Supplement. 2001, Vol 62, Num 23, pp 23-29Conference Paper
Metabolic Syndrome and Elevated C-Reactive Protein Levels in Elderly Patients With Newly Diagnosed DepressionSOYEON PARK; YEON HO JOO; MCINTYRE, Roger S et al.Psychosomatics (Washington, DC). 2014, Vol 55, Num 6, pp 640-649, issn 0033-3182, 10 p.Article